Bank Of America Corp Adma Biologics, Inc. Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
A detailed history of Bank Of America Corp transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 766,224 shares of ADMA stock, worth $14.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
766,224
Previous 479,655
59.74%
Holding current value
$14.3 Million
Previous $9.59 Million
37.05%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$348 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$340 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$278 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$211 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$103 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.67B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...